Suppr超能文献

旨在改善接受基于雌二醇/孕酮定时人工授精方案的印度瘤牛繁殖性能的激素组合。

Hormonal combinations aiming to improve reproductive outcomes of Bos indicus cows submitted to estradiol/progesterone-based timed AI protocols.

作者信息

Alves Rodrigo L O R, Silva Mateus A, Consentini Carlos E C, E Silva Lucas O, Folchini Natália P, Oliva Abraham L, Prata Alexandre B, Gonçalves José Renato S, Wiltbank Milo C, Sartori Roberto

机构信息

Department of Animal Science, Luiz de Queiroz College of Agriculture, University of São Paulo (ESALQ/USP), Piracicaba, SP, 13418-900, Brazil.

Cuautitlán Higher Education Faculty-UNAM, Cuautitlán Izcalli, 54740, Mexico.

出版信息

Theriogenology. 2021 Jul 15;169:89-99. doi: 10.1016/j.theriogenology.2021.04.007. Epub 2021 Apr 18.

Abstract

The aim was to study reproductive outcomes of Nelore (Bos indicus) cows submitted to a 7-d estradiol (E2)/progesterone (P4)-based timed artificial insemination (TAI) protocol, receiving various combinations of doses and hormones. Primiparous (n = 962) and multiparous (n = 1935) cows were submitted to synchronization (n = 2012) and resynchronization (n = 885 non-pregnant cows at pregnancy diagnosis 30 d after TAI) protocols, following a 2 × 2 × 2 factorial arrangement of eight treatments. At the initiation of the TAI protocol (Day -9), all cows received a 1.0 g intravaginal P4 insert, 2.0 mg E2 benzoate and received (PGF1) or not (PGF0) 0.5 mg cloprostenol sodium (PGF). On Day -2, the P4 insert was removed, all cows received 0.5 mg PGF, 300 IU equine chorionic gonadotropin (eCG) and 0.5 (EC0.5) or 1.0 mg estradiol cypionate (EC1.0). On Day 0, cows were treated (G1) with 8.4 μg buserelin acetate (GnRH) or not (G0), concurrently with TAI. The eight treatments were generated: 1) PGF0-EC0.5-G0 (n = 364), 2) PGF0-EC0.5-G1 (n = 363), 3) PGF1-EC0.5-G0 (n = 363), 4) PGF1-EC0.5-G1 (n = 360), 5) PGF0-EC-1.0-G0 (n = 360), 6) PGF0-EC1.0-G1 (n = 363), 7) PGF1-EC1.0-G0 (n = 361), and 8) PGF1-EC1.0-G1 (n = 363). Pregnancy per AI (P/AI) was greater at first AI compared with resynchronization (58.9 [n = 2012] vs. 54.9% [n = 885]). Presence of CL on Day -9 resulted in more cows expressing estrus (81.3 [n = 680] vs. 67.1% [n = 2033]) and greater P/AI (66.0 [n = 692] vs. 54.9% [n = 2106]). There was no difference in P/AI between cows that received or not PGF on Day -9 (58.7 [n = 1447] vs. 56.6% [n = 1450]). In contrast, PGF tended to increase P/AI of cows with CL on Day -9 (with PGF = 69.1 [n = 375] vs. without PGF = 62.5% [n = 317]). Cows that received 1.0 mg EC expressed more estrus than those treated with 0.5 mg (73.8 [n = 1414] vs. 67.9% [n = 1398]) and had greater P/AI (60.2 [n = 1447] vs. 55.1% [n = 1450]). P/AI was greater in cows treated with GnRH at TAI (59.8 [n = 1449] vs. 55.5% [n = 1448]), particularly in cows that did not show estrus (52.7 [n = 393] vs. 38.1% [n = 420]). Moreover, GnRH on Day 0 increased P/AI in cows with BCS < 3.0 (57.1 [n = 723] vs. 48.6% [n = 698]), in primiparous (50.1 [n = 465] vs. 41.9% [n = 497]) and in cows that received 0.5 mg EC (58.9 [n = 723] vs. 51.3% [n = 727]). In conclusion, 1.0 mg of EC on Day -2 and GnRH at TAI improved P/AI, but the combination of a higher dose of EC and GnRH treatment at AI did not enhance this effect. Furthermore, GnRH improved P/AI especially in Bos indicus cows with lower expression of estrus, such as primiparous, thinner cows, and cows treated with 0.5 mg of EC.

摘要

本研究旨在探讨接受基于7天雌二醇(E2)/孕酮(P4)的定时人工授精(TAI)方案、使用不同剂量和激素组合的内洛尔牛(印度瘤牛)的繁殖结果。初产牛(n = 962)和经产牛(n = 1935)按照2×2×2析因设计的8种处理方法,接受同期发情(n = 2012)和再同期发情(TAI后30天妊娠诊断时未怀孕的885头牛)方案。在TAI方案开始时(第-9天),所有母牛都植入1.0 g阴道孕酮栓,注射2.0 mg苯甲酸雌二醇,并接受(PGF1)或不接受(PGF0)0.5 mg氯前列醇钠(PGF)。在第-2天,取出孕酮栓,所有母牛都注射0.5 mg PGF、300 IU马绒毛膜促性腺激素(eCG)和0.5(EC0.5)或1.0 mg环丙孕酮(EC1.0)。在第0天,母牛在进行TAI的同时,接受(G1)或不接受(G0)8.4 μg醋酸布舍瑞林(GnRH)治疗。由此产生了8种处理:1)PGF0-EC0.5-G0(n = 364),2)PGF0-EC0.5-G1(n = 363),3)PGF1-EC0.5-G0(n = 363),4)PGF1-EC0.5-G1(n = 360),5)PGF0-EC-1.0-G0(n = 360),6)PGF0-EC1.0-G1(n = 363),7)PGF1-EC1.0-G0(n = 361),8)PGF1-EC1.0-G1(n = 363)。首次人工授精的妊娠率(P/AI)高于再同期发情(58.9%[n = 2012]对54.9%[n = 885])。第-9天存在黄体导致更多母牛表现出发情(81.3%[n = 680]对67.1%[n = 2033])和更高的P/AI(66.0%[n = 692]对54.9%[n = 2106])。第-9天接受或未接受PGF的母牛之间的P/AI没有差异(58.7%[n = 1447]对56.6%[n = 1450])。相比之下,PGF倾向于提高第-9天有黄体的母牛的P/AI(使用PGF = 69.1%[n = 375]对未使用PGF = 62.5%[n = 317])。接受1.0 mg EC的母牛比接受0.5 mg EC的母牛表现出更多发情(73.8%[n = 1414]对67.9%[n = 1398]),并且P/AI更高(60.2%[n = 1447]对55.1%[n = 1450])。在TAI时接受GnRH治疗的母牛的P/AI更高(59.8%[n = 1449]对55.5%[n = 1448]),特别是在未表现出发情的母牛中(52.7%[n = 393]对38.1%[n = 420])。此外,第0天的GnRH提高了体况评分<3.0的母牛的P/AI(57.1%[n = 723]对48.6%[n = 698])、初产牛(50.1%[n = 465]对41.9%[n = 497])以及接受0.5 mg EC的母牛的P/AI(58.9%[n = 723]对51.3%[n = 727])。总之,第-2天的1.0 mg EC和TAI时的GnRH提高了P/AI,但更高剂量的EC和AI时的GnRH治疗组合并未增强这种效果。此外,GnRH尤其提高了发情表现较低的印度瘤牛的P/AI,如初产牛、较瘦的母牛以及接受0.5 mg EC治疗的母牛。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验